NFH
ATHE

NEXT Financial Holdings’s Alterity Therapeutics ATHE Stock Holding History

NEXT Financial Holdings’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1K Buy
+58
New +$987 ﹤0.01% 1536

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

NEXT Financial Holdings's ATHE Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Alterity Therapeutics (ATHE) in Q1 2019: 58 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1536 among its holdings.

8 funds tracked by Wall St. Rank hold ATHE as of Q1 2019.

  • NEXT Financial Holdings held 58 shares of Alterity Therapeutics worth $1K as of Q1 2019.
  • Alterity Therapeutics was a new NEXT Financial Holdings position in Q1 2019.
  • Alterity Therapeutics made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1536 holding.
  • 8 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.